Skip to main content

C50.3 vs D48.6

C50.3 (Malignant neoplasm of lower-inner quadrant of breast) compared with D48.6 (Neoplasm of uncertain behavior of breast), from the official CMS tabular data. C50.3 and D48.6 name the same anatomical site (breast) with a different neoplasm behavior.

Relationship

Informational

Neoplasm table relationship

C50.3
Malignant neoplasm of lower-inner quadrant of breast
D48.6
Neoplasm of uncertain behavior of breast

Same anatomical site, different neoplasm behavior.

Same site — uncertain behavior (breast)

The behavior documented for the site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column of the neoplasm table, and therefore which code, applies.

Source: CMS Table of Neoplasms

Can these codes be reported together?

Same site, different neoplasm behavior. C50.3 and D48.6 name the same anatomical site (breast) with a different neoplasm behavior.

From the CMS Table of Neoplasms: the behavior documented for that site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column, and therefore which code, applies.

Side by side

C50.3Malignant neoplasm of lower-inner quadrant of breastD48.6Neoplasm of uncertain behavior of breast
Billing statusNon-billable header

Report instead: C50.311, C50.312, C50.319, C50.321, C50.322

Non-billable header

Report instead: D48.60, D48.61, D48.62

ClassificationC00-D49 — NeoplasmsC00-D49 — Neoplasms
DefinitionMalignant neoplasm of lower-inner quadrant of breast is a non-billable ICD-10-CM category code (C50.3).Neoplasm of uncertain behavior of breast is a non-billable ICD-10-CM category code (D48.6).
Includes
connective tissue of breast
Paget's disease of breast
Paget's disease of nipple
Neoplasm of uncertain behavior of connective tissue of breast
Cystosarcoma phyllodes
Use additional code
code to identify estrogen, and other hormones and factors receptor status (Z17.-)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources